Pseudouridylation goes regulatory.

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

5 citing papers in PubMed.

1. Deciphering the pseudouridine nucleobase modification in human diseases: From molecular mechanisms to clinical perspectives.Clinical and translational medicine · 2025
   Review
2. RNA Methylation in ncRNA: Classes, Detection, and Molecular Associations.Frontiers in genetics · 2018
   Article
3. Transcriptome-wide dynamics of RNA pseudouridylation.Nature reviews. Molecular cell biology · 2015
   Review
4. RNA-guided isomerization of uridine to pseudouridine--pseudouridylation.RNA biology · 2014
   Review
5. RNA pseudouridylation: new insights into an old modification.Trends in biochemical sciences · 2013
   Review

Corrections and comments

• Comment on
  U2 snRNA is inducibly pseudouridylated at novel sites by Pus7p and snR81 RNP.2011

Authors and funding

1 author.

Funding

Abstract

PubMed holds no abstract for this paper.

Indexed as